Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0380
-0.0010 (-2.56%)
Sep 11, 2026, 3:44 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 12.9 million as of September 11, 2026. Its market cap has increased by 3.74% in one year.
Market Cap
12.90M
Enterprise Value
14.12M
Revenue
2.92M
Ranking
n/a
PE Ratio
3.80
Stock Price
0.04
ChartMarket Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 12.90M, a decrease of -86.45%. That is a compound annual growth rate of -28.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.90M | 36.28% |
| Dec 31, 2025 | 9.47M | 54.80% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 25.81B |
| EBOS Group | 4.15B |
| Ryman Healthcare | 1.99B |
| Summerset Group Holdings | 1.94B |
| Pacific Edge | 316.67M |
| Green Cross Health | 280.48M |
| Radius Residential Care | 120.47M |
| Third Age Health Services | 46.29M |